Part of our responsibility as a global pharmaceutical company is to ensure the safety of the patients who use our products. At Hikma, we are committed to drug safety as long as the medicine is prescribed to patients.

Hikma follows strict regulatory requirements and guidelines to monitor, collect and analyze adverse events associated with its products and communicate with the regulatory authorities where necessary.

Hikma has systems in place throughout the Hikma Group to promptly respond to customer complaints, and to ensure that all staff members immediately report any issues relating to the safety or quality of Hikma’s products.